Sign in →

Order Code PBALP Porphobilinogen and Aminolevulinic Acid, Plasma


Shipping Instructions


Ship specimens refrigerated or frozen and in amber vial to protect from light.



Necessary Information


Include a list of medications the patient is currently taking.



Specimen Required


Patient Preparation: Patient must not consume any alcohol for at least 24 hours prior to specimen collection.

Supplies: Amber Frosted Tube, 5mL (T915)

Collection Container/Tube:

Preferred: Green top (sodium heparin)

Acceptable: Green top (lithium heparin), lavender top (EDTA), yellow top (ACD A or B)

Submission Container/Tube: Amber vial

Specimen Volume: 1 mL

Collection Instructions:

1. It is recommended that specimen collection occur during the acute phase. Porphobilinogen and aminolevulinic acid may be normal when the patient is not exhibiting symptoms.

2. Centrifuge and aliquot plasma into plastic vial.


Useful For

An equivalent option to urine for first-line test for evaluation of a suspected acute porphyria

 

Monitoring patients undergoing treatment for an acute intermittent porphyria or other acute porphyria

Genetics Test Information

Plasma porphobilinogen and aminolevulinic acid (ALA) are elevated during the symptomatic phase of the acute porphyrias: acute intermittent porphyria (AIP), hereditary coproporphyria, and variegate porphyria.

 

An isolated elevation of ALA may be due to the very rare ALA dehydratase deficiency porphyria (ADP) or more commonly, a secondary inhibition of ALA dehydratase.

 

This test can be used as part of the diagnostic assessment and monitoring of patients with AIP and other acute porphyrias.

 

If ordered for diagnostic purposes, results are most informative when the specimen is obtained while the patient is having symptoms.

 

Additional testing must be performed to distinguish among the acute porphyrias.

Method Name

Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)

Reporting Name

PBG and ALA, P

Specimen Type

Plasma

Specimen Minimum Volume

0.3 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Plasma Frozen (preferred) 21 days LIGHT PROTECTED
  Refrigerated  7 days LIGHT PROTECTED

Reject Due To

Gross hemolysis OK
Gross lipemia OK
Gross icterus OK

Reference Values

Porphobilinogen: ≤0.5 nmol/mL

Aminolevulinic Acid: ≤0.5 nmol/mL

Method Description

In a microcentrifuge tube, internal standard and plasma are combined, centrifuged, and then subjected to solid phase extraction (SPE). The SPE eluate is evaporated and the residue is then reconstituted and subjected to liquid chromatography tandem mass spectrometry analysis.(Unpublished Mayo method)

Day(s) Performed

Wednesday

Performing Laboratory

Mayo Clinic Laboratories in Rochester

CPT Code Information

82542

82135